On 1 December 2023, Ana-Maria Šimundić took up the newly created position as Director of Global Medical & Clinical Affairs at Greiner Bio-One. In this role, she heads the Global Medical & Clinical Affairs department and will represent Greiner Bio-One in national and international professional circles as well as foster exchange with experts in science […]
Research partnership aims to build strong pharma and academic collaborations in sharing data and clinical samples to develop biomarker-based diagnostics for Alzheimer’s Disease
PinPoint Testing, an innovator in analytical chemistry technology, is proud to announce the unveiling of a revolutionary patent-pending technology, Suspended StateTM. This groundbreaking advancement is a culmination of nearly 2-years of research and development by Dr. Jeffery Moran and his team of trained toxicologists and product designers.
Innovation Provides United States with First Workflow Update in 25 Years INDIANAPOLIS – (December 4, 2023) – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, has received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its popular AQUIOS STEM System in the United States.
Scantox, together with its majority owner Impilo, has agreed to acquire the neuropharmacology division of QPS Austria GmbH (“QPS Neuro” or “the Company”) ultimately owned by QPS Holdings LLC.
Nanologica expands its product portfolio of purification medias for preparative chromatography and has received a trial order worth approximately MSEK 3.6 from a customer in Asia.
Latest technologies in energy efficiency have been incorporated, such as geothermal energy, in addition to solar collection panels and electric car chargers
INTEGRA Biosciences has extended its reagent reservoir portfolio to include 10 and 25 ml sterile polypropylene reservoirs with SureFlo™ anti-sealing technology. The latest additions to the range are manufactured from a highly chemically resistant material offering a broad reagent compatibility and reduced surface adsorption of proteins, making them ideal for sensitive molecular assays.
Thrombosis is the process of blood clot formation in blood vessels causing life-threatening venous thromboembolic events (VTE) like a pulmonary embolism (PE).
The EURORealTime SARS-CoV-2 from EUROIMMUN is now validated for use with saliva as sample material as an alternative to throat swabs. Collection of saliva specimens is easier and less distressing for patients than taking nasal or throat swabs, especially for children.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
